{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:58:42Z","timestamp":1790531922748,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jpba.2019.112792","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T11:41:00Z","timestamp":1564054860000},"page":"112792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Two validated liquid chromatography\u2013mass spectrometry methods with different pretreatments for the quantification of an anti-CD47 monoclonal antibody in rat and cynomolgus monkey serum compared with an electrochemiluminescence method"],"prefix":"10.1016","volume":"175","author":[{"given":"Yuxiong","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2019.112792_bib0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/19420862.2018.1415671","article-title":"Antibodies to watch in 2018","volume":"10","author":"Kaplon","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.jpba.2019.112792_bib0010","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/acschemneuro.7b00253","article-title":"New 2016 data and statistics for global pharmaceutical products and projections through 2017","volume":"8","author":"Lindsley","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jpba.2019.112792_bib0015","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1208\/aapsj0901004","article-title":"Workshop\/conference report\u2014quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays","volume":"9","author":"Viswanathan","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2019.112792_bib0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12026-014-8491-6","article-title":"Effects of serum and plasma matrices on multiplex immunoassays","volume":"58","author":"Rosenberg-Hasson","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jpba.2019.112792_bib0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/clpt.2008.170","article-title":"Monoclonal antibody pharmacokinetics and pharmacodynamics","volume":"84","author":"Wang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2019.112792_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd984","article-title":"Therapeutic antibodies for human diseases at the dawn of the twenty-first century","volume":"2","author":"Brekke","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2019.112792_bib0035","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1208\/aapsj0902017","article-title":"Key elements of bioanalytical method validation for macromolecules","volume":"9","author":"Kelley","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2019.112792_bib0040","first-page":"22","article-title":"A risk-based approach to immunogenicity concerns of therapeutic protein products part 1 considering consequences of the immune response to a protein","volume":"17","author":"Rosenberg","year":"2004","journal-title":"Biopharm. Int."},{"key":"10.1016\/j.jpba.2019.112792_bib0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nbt1303","article-title":"A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs","volume":"25","author":"Shankar","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jpba.2019.112792_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2008.01.001","article-title":"Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products","volume":"333","author":"Shankar","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2019.112792_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/HAB-2009-0206","article-title":"Bioanalytical methods for the quantification of therapeutic monoclonal antibodies and their application in clinical pharmacokinetic studies","volume":"18","author":"Damen","year":"2009","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.jpba.2019.112792_bib0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1208\/s12248-011-9251-3","article-title":"Bioanalytical approaches to quantify \"total\" and \"free\" therapeutic antibodies and their targets: technical challenges and PK\/PD applications over the course of drug development","volume":"13","author":"Lee","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2019.112792_bib0065","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1021\/ac0515531","article-title":"Quantification of small therapeutic proteins in plasma by liquid chromatography-tandem mass spectrometry: application to an elastase inhibitor EPI-hNE4","volume":"78","author":"Becher","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2019.112792_bib0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jchromb.2006.12.053","article-title":"Quantitative analysis of tenecteplase in rat plasma samples using LC\u2013MS\/MS as an alternative for ELISA","volume":"852","author":"Buscher","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2019.112792_bib0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/rcm.4856","volume":"25","author":"Wu","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2019.112792_bib0080","first-page":"147","article-title":"Quantitation of a recombinant monoclonal antibody in monkey serum by liquid chromatography\u2013mass spectrometry","volume":"414","author":"Liu","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2019.112792_bib0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0962-8924(00)01906-1","article-title":"Integrin-associated protein (CD47) and its ligands","volume":"11","author":"Brown","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jpba.2019.112792_bib0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejca.2017.02.013","article-title":"Cancer immunotherapy targeting the CD47\/SIRP\u03b1 axis","volume":"76","author":"Weiskopf","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jpba.2019.112792_bib0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2968","article-title":"Disrupting the CD47-SIRP\u03b1 anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors","volume":"9","author":"Gholamin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jpba.2019.112792_bib0100","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1021\/pr900001t","article-title":"A straightforward and highly efficient precipitation\/on-pellet digestion procedure coupled with a long gradient nano-LC separation and orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome","volume":"8","author":"Duan","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpba.2019.112792_bib0105","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1021\/ac2034166","article-title":"High-throughput method development for sensitive, accurate, and reproducible quantification of therapeutic monoclonal antibodies in tissues using orthogonal array optimization and nano liquid chromatography\/selected reaction monitoring mass spectrometry","volume":"84","author":"Duan","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2019.112792_bib0110","series-title":"General Chapter 0912","author":"Chinese Pharmacopoeia Commission","year":"2015"},{"key":"10.1016\/j.jpba.2019.112792_bib0115","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency (EMA)","year":"2012"},{"key":"10.1016\/j.jpba.2019.112792_bib0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","article-title":"The immunogenicity of humanized and fully human antibodies","volume":"2","author":"Harding","year":"2010","journal-title":"MAbs"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519309446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519309446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:58:46Z","timestamp":1760000326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519309446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":24,"alternative-id":["S0731708519309446"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.112792","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two validated liquid chromatography\u2013mass spectrometry methods with different pretreatments for the quantification of an anti-CD47 monoclonal antibody in rat and cynomolgus monkey serum compared with an electrochemiluminescence method","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.112792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112792"}}